Role of c-Jun N-terminal kinase (JNK) in obesity and type 2 diabetes

JHM Yung, A Giacca - Cells, 2020 - mdpi.com
Obesity has been described as a global epidemic and is a low-grade chronic inflammatory
disease that arises as a consequence of energy imbalance. Obesity increases the risk of …

Oxidative stress in obesity-associated hepatocellular carcinoma: sources, signaling and therapeutic challenges

MK Brahma, EH Gilglioni, L Zhou, E Trépo, P Chen… - Oncogene, 2021 - nature.com
Obesity affects more than 650 million individuals worldwide and is a well-established risk
factor for the development of hepatocellular carcinoma (HCC). Oxidative stress can be …

[HTML][HTML] Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma

S Talamantes, M Lisjak, EH Gilglioni… - JHEP Reports, 2023 - Elsevier
Obesity-related complications such as non-alcoholic fatty liver disease (NAFLD) and type 2
diabetes (T2D) are well-established risk factors for the development of hepatocellular …

[HTML][HTML] Oxidative stress and redox signaling in the pathophysiology of liver diseases

RGR Mooli, D Mukhi… - Comprehensive …, 2022 - ncbi.nlm.nih.gov
The increased production of derivatives of molecular oxygen and nitrogen in the form of
reactive oxygen species (ROS) and reactive nitrogen species (RNS) lead to molecular …

PYCR1 interference inhibits cell growth and survival via c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathway in hepatocellular cancer

J Zhuang, Y Song, Y Ye, S He, X Ma, M Zhang… - Journal of translational …, 2019 - Springer
Background Liver cancer is the second leading causes of cancer-related death globally.
Pyrroline-5-carboxylate reductase 1 (PYCR1) plays a critical role in metabolic profiles of …

JNK signaling pathway in metabolic disorders: An emerging therapeutic target

R Garg, S Kumariya, R Katekar, S Verma… - European Journal of …, 2021 - Elsevier
Metabolic Syndrome is a multifactorial disease associated with increased risk of
cardiovascular disorders, type 2 diabetes mellitus, fatty liver disease, etc. Various stress …

Exercise inhibits JNK pathway activation and lipotoxicity via macrophage migration inhibitory factor in nonalcoholic fatty liver disease

N Cui, H Li, Y Dun, JW Ripley-Gonzalez… - Frontiers in …, 2022 - frontiersin.org
The macrophage migration inhibitory factor (MIF) expressed in hepatocytes can limit
steatosis during obesity. Lipotoxicity in nonalcoholic fatty liver disease is mediated in part by …

Adiposity and serum selenium in US adults

Q Zhong, R Lin, Q Nong - Nutrients, 2018 - mdpi.com
Requirements for selenium and other antioxidant nutrients are increased in pro-oxidant and
pro-inflammatory conditions such as excess adiposity. Data concerning the association of …

JNK1 and ERK1/2 modulate lymphocyte homeostasis via BIM and DRP1 upon AICD induction

L Simula, M Corrado, B Accordi, A Di Rita… - Cell Death & …, 2020 - nature.com
Abstract The Activation-Induced Cell Death (AICD) is a stimulation-dependent form of
apoptosis used by the organism to shutdown T-cell response once the source of …

Molecular genealogy of metabolic-associated hepatocellular carcinoma

T Kodama, T Takehara - Seminars in Liver Disease, 2024 - thieme-connect.com
This review examines the latest epidemiological and molecular pathogenic findings of
metabolic-associated hepatocellular carcinoma (HCC). Its increasing prevalence is a …